Key UCI CCR Contacts

Dr. Senthil is a clinical professor of surgery and the John Wayne Cancer Foundation endowed chair in the Department of Surgery. She is a nationally recognized surgical oncologist and surgeon-scientist with a special expertise in the management of patients with peritoneal carcinomatosis and advanced malignancies. She is also division chief for surgical oncology in the Department of Surgery, where she leads a strong, multi-institutional translational research program and serves as a primary investigator for many clinical studies, several of which she has initiated. Dr. Senthil’s appointment will provide the governance and leadership, market differentiation and growth, and process oversight and stakeholder experience the CCR will need to continue its upward trajectory and to adapt to the current and future needs of our researchers and the community.

Dr. Alger joins UCI from Gilead Sciences, Inc., where she served as regulatory compliance global lead for the Americas and Asia. In this capacity, she was responsible for regulatory compliance and quality oversight worldwide for research and development groups conducting preclinical and clinical research, and pharmacovigilance activities for both investigational and post-approval products. Prior to Gilead Sciences, she served as director of compliance for the City of Hope National Medical Center. Dr. Alger also previously served as the research compliance officer for the UCI Medical Center.

Jessica joins our team from the UCI Cancer Center where she worked as a Clinical Research Manager and managed a team of 16 direct reports. She oversaw five disease site clinical trial portfolios, performed administrative and clinical operations for 160 trials and approximately 260 patients. Additionally, she developed SOPs to ensure compliance, worked with Medical Center Faculty and departments, and developed investigator-initiated trial protocols. Jessica’s background also includes assisting with industry sponsor budget and contract negotiations. Prior to UCI, Jessica worked for Eisenhower Health as a Clinical Research Associate. In her new role, Jessica is responsible for managing operations of the UCI Center for Clinical Research (CCR) and the associated quality, regulatory, and administrative functions of all clinical research activities.

With a Bachelor of Science in Economics from Arizona State University and a Master of Public Health in Health Policy and Management from Columbia University, Stephen brings nearly two decades of experience in research finance management at prestigious academic institutions such as Columbia and USC to his role at UCI. With a proven track record in managing industry-sponsored and federally funded clinical trials, Stephen has a wealth of knowledge in the field of clinical research. His expertise and leadership are a valuable asset to our team at UCI Center for Clinical Research, and we're thrilled to have him on board.

With a background in Cognitive and Biological Science, Dani is a proud UC Irvine alumna who has amassed a decade of experience in clinical trial and research. She joined the CCR in 2021 as a Recruitment Specialist, where her specific focus on research recruitment and enrollment strategies has been instrumental at CCR.In her current role as the Assistant Director of Business Development and Technology, Dani is responsible for expanding the CCR's profile of clinical trials, cultivating new business opportunities with industry sponsors, and managing key client relationships. She is also in charge of establishing data analytics, dashboards, and reporting functionalities for CCR stakeholders. Her creative and innovative approach to community engagement, through avenues such as newsletters, events, platforms, and campaigns, enables patients to have access to the latest clinical trials. Dani's unique set of skills, including her business development and creative thinking abilities, are a vital component of the CCR team. We are thrilled to have her on board and are confident that her contributions will help to take our organization to new heights.